Pay-for-delay: The Korean experience
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, H. | - |
dc.date.accessioned | 2021-09-05T16:15:45Z | - |
dc.date.available | 2021-09-05T16:15:45Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 2041-7764 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/100855 | - |
dc.description.abstract | [No abstract available] | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Oxford University Press | - |
dc.title | Pay-for-delay: The Korean experience | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, H. | - |
dc.identifier.doi | 10.1093/jeclap/lpu018 | - |
dc.identifier.scopusid | 2-s2.0-84979084141 | - |
dc.identifier.bibliographicCitation | Journal of European Competition Law and Practice, v.5, no.4, pp.221 - 226 | - |
dc.relation.isPartOf | Journal of European Competition Law and Practice | - |
dc.citation.title | Journal of European Competition Law and Practice | - |
dc.citation.volume | 5 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 221 | - |
dc.citation.endPage | 226 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | pay-for-delay | - |
dc.subject.keywordAuthor | reverse payment | - |
dc.subject.keywordAuthor | exclusivity | - |
dc.subject.keywordAuthor | Hatch Waxman | - |
dc.subject.keywordAuthor | generic drug | - |
dc.subject.keywordAuthor | settlement agreement | - |
dc.subject.keywordAuthor | scope of patents | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.